|
Sign In to gain access to subscriptions and/or personal tools.
|
Validity of performance scales for disability assessment in multiple sclerosis
R.A. Marrie
Department of Neurology, Cleveland Clinic, Cleveland, OH, USA, marrier{at}ccf.org
M. Goldman
Department of Neurology, University of Virginia, Charlottesville, VA, USA
Researchers increasingly use self-reported health status assessments, but these require validation. Performance Scales (PS) is a self-report measure for multiple sclerosis (MS)-associated disability, assessing mobility, bowel/bladder, fatigue, sensory, vision, cognition, spasticity and hand function. The criterion validity of the total PS score was established using the Expanded Disability Status Scale (EDSS), but the construct and criterion validity of the individual subscales have not been established. We assessed the criterion and construct validity of the PS subscales. Forty-four patients with MS completed PS, and these criterion measurements: neurological examination (EDSS), the Multiple Sclerosis Functional Composite (MSFC), contrast acuity testing, and the Multiple Sclerosis Quality of Life Inventory. We assessed criterion and construct validity with Spearman rank correlations between PS subscales and the other measurements. PS correlated with the MSFC (r = -0.58, P < 0.0001). The mobility, hand, vision, fatigue and bladder subscales correlated with their criterion measures (r = 0.59—0.77, P < 0.0001). The sensory subscale correlated weakly with the sensory functional system score (r = 0.39, P = 0.01 ), and the cognitive subscale did not correlate with the PASAT (r = -0.17, P = 0.26). This study supports the criterion and construct validity of PS overall, and its mobility, hand, vision, fatigue, and bladder subscales. Further assessment of the cognitive, sensory and spasticity subscales is needed. Multiple Sclerosis 2007; 13: 1176—1182. http://msj.sagepub.com
Key Words: multiple sclerosis • validity • disability • performance scales • MSFC • self-report
References
- Schwartz CE, Vollmer T., Lee H., North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Reliability and validity of two self-report measures of impairment and disability for MS. Neurology 1999; 52: 63—71.[Abstract/Free Full Text]
- Whitaker JN, McFarland HF, Rudge P., Reingold SC Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Multiple Sclerosis 1995; 1: 37—47.[Medline]
[Order article via Infotrieve]
- Marrie RA, Cohen JA Appraisal of the Multiple Sclerosis Functional Composite. Expert Review of Neurotherapeutics 2003; 3: 335—41.[CrossRef]
- Goldman MD A study of a motor fatigue outcome measurement in multiple sclerosis patients. Case Western Reserve University, 2006.
- McDonald WI, Compston A., Edan G., Goodkin D., Hartung H-P., Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001; 50: 121—27.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kurtzke JF Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444—52.[Abstract/Free Full Text]
- Rudick RA, Cutter G., Reingold S. The multiple sclerosis functional composite: a new clinical outcome measure for multiple sclerosis trials. Multiple Sclerosis 2002; 8: 359—65.[Abstract/Free Full Text]
- Balcer LJ, Baier ML, Cohen JA, Kooijmans MF, Sandrock AW, Nano-Schiavi ML et al. Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology 2003; 61: 1367—73.[Abstract/Free Full Text]
- Balcer LJ, Baier ML, Pelak VS, Fox RJ, Shuwairi S., Galetta SL et al. New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Multiple Sclerosis 2000; 6: 163—71.[Abstract/Free Full Text]
- Baier ML, Cutter GR, Rudick RA, Miller D., Cohen JA, Weinstock-Guttman B. et al. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology 2005; 64: 992—95.[Abstract/Free Full Text]
- Hohol MJ, Orav EJ, Weiner HL Disease Steps in multiple sclerosis: A simple approach to evaluate disease progression. Neurology 1995; 45: 251—55.[Abstract/Free Full Text]
- Hohol MJ, Orav EJ, Weiner HL Disease Steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Multiple Sclerosis 1999; 5: 349—54.[Abstract/Free Full Text]
- Ritvo PG, Fischer JS, Miller DM, Andrews H., Paty DW, LaRocca NG Multiple sclerosis quality of life inventory: A user's manual. National Multiple Sclerosis Society, 1997.
- Benrud-Larson LM, Wegener ST Chronic pain in neurorehabilitation populations: Prevalence, severity and impact. Neurorehabilitation 2000; 14: 127—37.[Web of Science][Medline]
[Order article via Infotrieve]
- Rizzo MA, Hadjimichael OC, Preiningerova J., Vollmer TL Prevalence and treatment of spasticity reported by multiple sclerosis patients. Multiple Sclerosis 2004; 10: 589—95.[Abstract/Free Full Text]
- Iriarte J., Subira ML, de Castro P. Modalities of fatigue in multiple sclerosis: Correlation with clinical and biological factors. Multiple Sclerosis 2000; 6: 124—30.[Abstract/Free Full Text]
- Ehde DM, Gibbons LE, Chwastiak L., Bombardier CH, Sullivan MD, Kraft GH Chronic pain in a large community sample of persons with multiple sclerosis. Multiple Sclerosis 2003; 9: 605—11.[Abstract/Free Full Text]
- Lerdal A., Celius EG, Moum T. Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Multiple Sclerosis 2003; 9: 509—14.[Abstract/Free Full Text]
- Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1993; 56: 245—50.
- Lublin FD, Reingold SC Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology 1996; 46: 907—11.[Abstract/Free Full Text]
- Lechner-Scott J., Kappos L., Hofman M., Polman CH, Ronner H., Montalban X. et al. Can the Expanded Disability Status Scale be assessed by telephone? Multiple Sclerosis 2003; 9: 154—59.[Abstract/Free Full Text]
- Verdier-Taillefer MH, Roullet E., Cesaro P., Alperovitch A. Validation of self-reported neurological disability in multiple sclerosis. International Journal of Epidemiology 1994; 23: 148—54.[Abstract/Free Full Text]
- Solari A., Amato MP, Bergamaschi R., Logroscino G., Citterio A., Bochicchio D. et al. Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis. Acta Neurologica Scandinavica 1993; 87: 43—46.[Web of Science][Medline]
[Order article via Infotrieve]
- Gulick EE, Cook SD, Troiano R. Comparison of patient and staff assessment of MS patients' health status. Acta Neurologica Scandinavica 1993; 88: 87—93.[Web of Science][Medline]
[Order article via Infotrieve]
- Bowen J., Gibbons L., Gianas A., Kraft GH Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test. Multiple Sclerosis 2001; 7: 201—206.[Abstract/Free Full Text]
- Marrie RA, Cutter G., Tyry T., Campagnolo D., Hadjimichael O., Vollmer T. Validation of the NARCOMS Registry: Fatigue Assessment. Multiple Sclerosis 2005; 11: 583—84.[Abstract/Free Full Text]
- Marrie RA, Cutter G., Tyry T., Vollmer T., Campagnolo D. Validation of the NARCOMS Registry: Bladder assessment. International Journal of MS Care 2006; 8: 61.
- Ma SL, Shea JA, Galetta SL, Jacobs DA, Markowitz CE, Maguire MG et al. Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. American Journal of Ophthalmology 2002; 133: 686—92.
- Frohman EM, Frohman TC, Zee DS, McColl R., Galetta S. The neuro-ophthalmology of multiple sclerosis. Lancet Neurology 2005; 4: 111—21.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. Neurology 1990; 40: 971—75.[Abstract/Free Full Text]
- Amato MP, Fratiglioni L., Groppi C., Siracusa G., Amaducci L. Interrater reliability in assessing Functional Systems and disability on the Kurtzke Scale in multiple sclerosis. Archives of Neurology 1988; 45: 746—48.
- Schwartz CE, Kozora E., Zeng Q. Towards patient collaboration in cognitive assessment: specificity, sensitivity, and incremental validity of self-report. Annals of Behavioral Medicine 1996; 18: 177—84.[CrossRef][Web of Science]
- Marrie RA, Chelune G., Miller DM, Cohen JA Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis. Multiple Sclerosis 2005; 11: 69—75.[Abstract/Free Full Text]
- Christodoulou C., Melville P., Scherl WF, Morgan T., Macallister WS, Canfora DM et al. Perceived cognitive dysfunction and observed neuropsychological performance: Longitudinal relation in persons with multiple sclerosis. Journal of the International Neuropsychological Society 2005; 11: 614—19.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Benedict Rhb, Munschauer F., Linn R., Miller C., Murphy E., Foley F. et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Multiple Sclerosis 2003; 9: 95—101.[Abstract/Free Full Text]
- Consortium of Multiple Sclerosis Centers. NARCOMS Multiple Sclerosis Registry [online]. Available at: www.mscare.org/narcoms.Accessed01/05/2002.
This version was published on November
1, 2007
Multiple Sclerosis, Vol. 13, No. 9,
1176-1182 (2007)
DOI: 10.1177/1352458507078388
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Panicker, D Nagaraja, J. Kovoor, K. Nair, and D. Subbakrishna
Lower urinary tract dysfunction in acute disseminated encephalomyelitis
Multiple Sclerosis,
September 1, 2009;
15(9):
1118 - 1122.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. F. Foley and D. W. Brandes
Redefining functionality and treatment efficacy in multiple sclerosis
Neurology,
June 9, 2009;
72(23_Supplement_5):
S1 - S11.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M Snook, R. W Motl, and R. C Gliottoni
The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis
Clinical Rehabilitation,
March 1, 2009;
23(3):
248 - 258.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. A. Marrie, R. Horwitz, G. Cutter, T. Tyry, D. Campagnolo, and T. Vollmer
Comorbidity delays diagnosis and increases disability at diagnosis in MS
Neurology,
January 13, 2009;
72(2):
117 - 124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Marrie, R Horwitz, G Cutter, T Tyry, D Campagnolo, and T Vollmer
High frequency of adverse health behaviors in multiple sclerosis
Multiple Sclerosis,
January 1, 2009;
15(1):
105 - 113.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Marrie, R Horwitz, G Cutter, T Tyry, D Campagnolo, and T Vollmer
Comorbidity, socioeconomic status and multiple sclerosis
Multiple Sclerosis,
September 1, 2008;
14(8):
1091 - 1098.
[Abstract]
[PDF]
|
|
|
|
|
